https://www.medicalnewstoday.com/articles/small-percentage-of-people-with-early-dementia-eligible-for-new-alzheimers-drugs
Researchers say most people with early Alzheimer's are not eligible to be treated with two newly approved monoclonal antibody drugs, lecanemab and aducanumab
Create an account or login to join the discussion